Certificate in Advanced Clinical Dementia Practice (ACDP)
To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.
Link to Course:
Web-based Certificate in Advanced Clinical Dementia Practice
This 34-hour distance-learning certificate offers:
- 31 hours of self-paced video lectures
- 3 hours of live drop-in case-based webinars (offered every other month)
Participants will gain clinical knowledge and skills in culturally-competent assessment, care planning, and state-of-the-art clinical intervention.
Participants will also learn strategies on how to apply these skills during client interactions and link with a multidisciplinary peer distance-learning community to practice new skills and discuss ideas.
The University of Michigan Medical School designates this enduring material for a maximum of 34.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Michigan School of Social Work, provider #1212, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org, through the Approved Continuing Education (ACE) program. The University of Michigan School of Social Work maintains responsibility for the program. ASWB Approval Period 5/15/2017-5/15/2020. Social workers should contact their regulatory board to determine course approval. Social workers participating in this course will receive 27.5 regular asynchronous online, 2 pain management asynchronous online, 1.5 ethics asynchronous online, and 3 regular live interactive online social work continuing education contact hours.
Nancy Barbas, MD
Daniel Kaplan, PhD
Leslie Dubin, MSW
Nancy Barbas, Michelle Barclay, Mary Blazek, Roxanne Chang, Leslie Dubin, Caroline Gelman, Bruno Giordani, Benjamin Hampstead, Helen Kales, Jennifer Howard, Daniel Kaplan, Daniel Kuhn, Anne Mondro, Anna Ortigara, Daniel Potts, Laura Rice-Oeschger, Scott Roberts, Beth Spencer, Laura Struble, Caroline Vitale
Financial Disclosure Information:
Nancy Barbas receives grant/research support from Eisai Pharmaceuticals. Michelle Barclay is a paid consultant to ACT and her organization, The Barclay Group, is a paid consultant to Ely Lilly. There are no other relevant financial relationships with ACCME-defined commercial interests to disclose for this activity.